Registration terms for new drugs remarkably to shorten

Published: 2002-02-21 07:00:00
Updated: 2002-02-21 07:00:00
When the preliminary review system for the protocol of clinical studies being exercised, the new drug registration process seems to be remarkably shortened effective from 2003.

The KFDA intends to charge the review fees at 6 million won per case and at 4.5 million won for other additional info...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.